Company / FCF Margin
NEUROONE MEDICAL TECHNOLOGIES Corp FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-322.4%
FY2025
5-year range
-4866.7% / -322.4%
FY2021-FY2025
Trend
+52.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has increased for 3 consecutive years, from -4866.7% in FY2022 to -322.4% in FY2025.
Based on SEC 10-K filings.
-322.4% in FY2025 with a 3-year CAGR of +4544.4%.
Improved from -4553.8% to -322.4% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +4544.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 52.6% year-over-year.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -322.4% | +52.6% |
| FY2024 | -679.7% | +85.1% |
| FY2023 | -4553.8% | +6.4% |
| FY2022 | -4866.7% | -144.4% |
| FY2021 | -1991.5% | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026